* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download OMB No. 0925-0046, Biographical Sketch Format Page
Transgenerational epigenetic inheritance wikipedia , lookup
Gene expression programming wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Long non-coding RNA wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Epigenetics wikipedia , lookup
History of genetic engineering wikipedia , lookup
Epigenomics wikipedia , lookup
Genome (book) wikipedia , lookup
Gene expression profiling wikipedia , lookup
Genetic engineering wikipedia , lookup
Gene therapy wikipedia , lookup
Microevolution wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Public health genomics wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Epigenetics in stem-cell differentiation wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Designer baby wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
BIOGRAPHICAL SKETCH Provide the following information for the Senior/key personnel and other significant contributors. Follow this format for each person. DO NOT EXCEED FIVE PAGES. NAME: Christine Cheng eRA COMMONS USER NAME (credential, e.g., agency login): CHENGCS POSITION TITLE: Assistant Professor of Biology EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and residency training if applicable. Add/delete rows as necessary.) DEGREE (if applicable) Completion Date MM/YYYY National Taiwan University B.S. 1996 Plant Biology Stanford University M.S. 2001 Computer Science University of California, San Diego Ph.D. 2011 Broad Institute of MIT and Harvard Postdoctoral 2016 Bioinformatics and Systems Biology Epigenetics, immunology, single cell INSTITUTION AND LOCATION FIELD OF STUDY A. Personal Statement This project proposes a novel approach to utilize massively parallel single-cell functional genomic assay that can profile simultaneously thousands of single cells in each experiment to study human genetics. We propose to develop an integrated single-cell resolution experimental and computational platform to identify genetic variants that are responsible for changes in gene expression and epigenetic states. Furthermore, we will validate the function of these genetic variants with massively parallel reporter assays in relevant cell types. My long-term research interest is in the development of a comprehensive understanding of the gene regulatory network and how aberrant regulatory circuits contribute to human disease, particularly in substance use disorder. With a background in both experimental biology and computational sciences, my research approach has been multi-interdisciplinary. During my Ph.D. and postdoctoral training, my main research interest was in understanding the transcriptional and epigenetic regulation of the innate and adaptive immune responses. As a graduate student with Dr. Alexander Hoffmann (UC San Diego), I combined top down (functional genomic methods) and bottom up (kinetic modeling) systems biology approaches to dissect the innate immune response transcriptional regulatory network (Cheng et al., Science Signaling 2011; Cheng et al., Cell Systems, accepted for publication). As a postdoctoral fellow in the lab of Dr. Aviv Regev (Broad Institute of MIT and Harvard), I developed a chromatin immunoprecipitation sequencing library preparation (ChIP-seq) protocol for the semiconductor based sequencing platform, Ion Torrent (Cheng et al., Nature Communications 2013). In my second project, I developed experimental and computational pipelines to map expression and epigenetic quantitative trait loci (eQTL and epigenetic-QTL) by profiling RNA-seq and chromatin accessibility (by ATAC-seq) in the primary T cells from 105 individuals (Cheng et al., Submitted to Science, in review). In my third project, I utilized recently developed massively parallel single-cell RNA-seq that allows profiling of thousands of individual single cells simultaneously and single-cell ATAC-seq to characterize the gene expression and epigenetic variability between individual bone marrow derived dendritic cells in response to pathogens (Cheng et al., in preparation). The focus of my laboratory at Boston University lies at the interface of experimental biology and bioinformatics, where we utilize and develop novel massively parallel single-cell epigenomic and transcriptomic technologies and apply these to characterize heterogeneous populations in clinical samples. For the long run, we will build computational models that allow us to predict disease progression and enable the development of personalized medicine in the future. B. Position and Honors Research positions 2000 Graduate Research Assistant, Stanford University, Genome Technology Center 2000-2001 Graduate Research Assistant, Stanford University, Department of Statistics 2003-2006 Graduate Research Assistant, University of California, San Diego. Mentor: Prof. Michael Rosenfeld 2006-2011 Graduate Research Assistant, University of California, San Diego. Thesis Advisor: Prof. Alexander Hoffmann 2011-2016 Postdoctoral Fellow, Broad Institute of MIT and Harvard, Cambridge, MA Mentor: Prof. Aviv Regev 2016-present Assistant Professor, Department of Biology, Bioinformatics Program, Boston University, Boston Visiting Scholar, Broad Institute of MIT and Harvard, Cambridge, MA Professional positions 2001-2002 Business Analyst, McKinsey and Company, Business Technology Office, Palo Alto, CA 2002-2003 Software Engineer, Oracle Corporation, Oracle Warehouse Builder Fellowships and Awards 2005-2008 DOD Army Breast Cancer Predoctoral Traineeship 2012-2015 NIH Individual Postdoctoral Fellowship C. Contribution to Science 1. Deciphering transcriptional regulatory network of the innate immune response by combining top down and bottom up approaches As a graduate student in the lab of Alexander Hoffmann at the University of California, San Diego I initiated a novel research direction by combing functional genomics (top down) and mechanistic modeling (bottom up) approaches to dissect transcriptional regulatory network in innate immune response. In my first study, I found a novel role of NFkB p50 homodimer in cross regulating a newly defined guanine-rich IRE motif in addition to the canonical NFkB binding motif. Mathematical modeling predicts that the newly identified role of NFkB p50 homodimer thereby restricting interferon signaling and antiviral immune responses only to appropriate pathogens and the prediction was validated with viral infection experiments in macrophages. In my second study, by probing the in vivo gene expression program with mathematical modeling of in silico genes, I have identified that the innate immune response gene activation program is simply composed of three major transcriptional pathways rather than 17 combinatorial gene regulatory pathways if we consider all possible combinatorial control. Furthermore, I did not observe transcriptional synergy between the three major pathways, instead, a novel class of regulation was identified, a synergistic AND gate between transcriptional regulation and regulated mRNA half live control. I was also involved in studies lead by Dr. Chris Glass and Dr. Steven Smale’s lab that characterized the underlying mechanism of innate immune response gene regulation at the chromatin and epigenetic level. 1. Cheng CS, Feldman KE, Lee J, Verma S, Huang DB, Huynh K, Chang M, Ponomarenko JC, Sun SC, Benedict CA, Ghosh G, Hoffmann A. The specificity of innate immune responses is enforced by B p50. Science Signaling. 2011 Feb 22;4(161):ra11. PMCID: PMC3096068 (Contributions: conceived study, designed/performed experiments and computational analysis, wrote manuscript) 2. Cheng CS*, Behar M*, Suryawanshi GW, Feldman KE, Spreafico R, Hoffmann A. The combinatorial control logic underlying pathogen-responsive gene expression programs involves sequential rather than coincident molecular mechanisms. Submitted to Cell Systems, accepted for publication. (Contributions: conceived study, designed/performed experiments and computational analysis, wrote manuscript) 3. Escoubet-Lozach L, Benner C, Kaikkonen MU, Lozach J, Heinz S, Spann NJ, Crotti A, Stender J, Ghisletti S, Reichart D, Cheng CS, Luna R, Ludka C, Sasik R, Garcia-Bassets I, Hoffmann A, Subramaniam S, Hardiman G, Rosenfeld MG, Glass CK. Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genet. 2011 Dec;7(12):e1002401. PMCID: PMC3234212 (Contribution: designed and performed experiments) 4. Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, Doty KR, Black JC, Hoffmann A, Carey M, Smale ST. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell. 2009 Jul 10;138(1):114-28. PMCID: PMC2712736 (Contribution: designed and performed computational analysis) 2. Development of various ChIP-seq based technologies The recent development of a semiconductor-based, non-optical DNA sequencing technology promises scalable, low-cost and rapid sequence data production. The technology has previously been applied mainly to genomic sequencing and targeted re-sequencing. As a postdoctoral fellow in Aviv Regev’s laboratory at the Broad Institute, I lead the development of a novel ChIP-seq library preparation method for the semiconductor-based sequencing technology, Ion Torrent. We demonstrate the utility of Ion Torrent semiconductor-based sequencing for sensitive, efficient and rapid chromatin immunoprecipitation followed by sequencing (ChIP-seq) through the application of sample preparation methods that are optimized for ChIP-seq on the Ion Torrent platform. We leverage this method for epigenetic profiling of tumour tissues. I was also involved in the development of a high-throughput ChIP-seq approach that allows tens of ChIP-seq experiments to be performed at the same time in a 96 well plate format with automated robotics. As a graduate student at UC San Diego, I was also involved in the development of a Sensitive ChIP-DSL technology and I also help developed with computational analysis of the resulted ChIP-seq data. 1. Cheng CS, Rai K, Garber M, Hollinger A, Robbins D, Anderson S, Macbeth A, Tzou A, Carneiro MO, Raychowdhury R, Russ C, Hacohen N, Gershenwald JE, Lennon N, Nusbaum C, Chin L, Regev A, Amit I. Semiconductor-based DNA sequencing of histone modification states. Nature Communications. 2013;4:2672. (Contributions: conceived study, designed/performed experiments and computational analysis, wrote manuscript) 2. Garber M, Yosef N, Goren A, Raychowdhury R, Thielke A, Guttman M, Robinson J, Minie B, Chevrier N, Itzhaki Z, Blecher-Gonen R, Bornstein C, Amann-Zalcenstein D, Weiner A, Friedrich D, Meldrim J, Ram O, Cheng C, Gnirke A, Fisher S, Friedman N, Wong B, Bernstein BE, Nusbaum C, Hacohen N, Regev A, Amit I. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol Cell. 2012 Sep 14;47(5):810-22. PMCID: PMC3873101 (Contribution: designed and performed experiments) 3. Garcia-Bassets I, Kwon YS, Telese F, Prefontaine GG, Hutt KR, Cheng CS, Ju BG, Ohgi KA, Wang J, Escoubet-Lozach L, Rose DW, Glass CK, Fu XD, Rosenfeld MG. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell. 2007 Feb 9;128(3):505-18. PMCID: PMC1994663 (Contribution: designed and performed computational analysis) 4. Kwon YS, Garcia-Bassets I, Hutt KR, Cheng CS, Jin M, Liu D, Benner C, Wang D, Ye Z, Bibikova M, Fan JB, Duan L, Glass CK, Rosenfeld MG, Fu XD. Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):4852-7. PMCID: PMC1821125 (Contribution: designed and performed computational analysis) 3. Utilizing variability between individual humans to identify gene variants that are associated with the variability in chromatin accessibility in activated primary human T cells As a postdoctoral fellow in Aviv Regev’s laboratory at the Broad Institute, I utilized epigenetic variability between individual humans as a perturbation tool to dissect transcriptional regulatory network. The vast majority of genetic variants associated with complex human traits map to non-coding and gene regulatory regions, but little is understood about how such genetic variants modulate gene regulation in health and disease. Utilizing a recently available assay, Assay for Transposase-Accessible Chromatin (ATAC-seq) for fast and sensitive epigenomic profiling of open chromatin, we performed ATAC-seq and RNA-seq in activated human CD4+ T cells from 100 healthy individuals to identify ATAC-QTLs: genetic variants associated with variability in chromatin accessibility. We found that ATAC-QTLs are widespread, disrupt binding sites for known transcription factors important for CD4+ T cell differentiation and activation, overlap and mediate expression QTLs from the same cells and are enriched for SNPs associated with autoimmune diseases. Measuring 3D chromosome organization in primary CD4+ T cells by in situ-Hi-C, we further show that ATAC-QTLs can simultaneously impact “multi-peaks” – multiple correlated open chromatin regions – and that such multi-peaks tend to reside in the same chromatin contact domains and are enriched in super enhancers. Thus, variability in chromatin accessibility in primary CD4+ T cells is heritable, determined by genetic variation in a manner affected by the 3D organization of the genome, and mediates genetic effects on gene expression variation. Our results provide insights into how genetic variants modulate chromatin state and gene expression in primary immune cells that play a key role in many human diseases. 1. Cheng CS*, Gate RE*, Aiden AP, Siba A, Tabaka M, Lituiev D, Machol I, Subramaniam M, MShamim M4, Hougen KL, Wortman I, Huang SC, Durand NC, Feng T, De Jager PL, Chang HY, Lieberman Aiden E, Benoist C, Beer MA, Ye CJ§, Regev A§. Genetic determinants of chromatin accessibility and gene regulation in T cell activation across human individuals. Submitted to Science, in review. (Contributions: conceived study, designed/performed experiments and computational analysis, wrote manuscript) 4. Utilizing variability between individual cells to dissect transcriptional regulatory network in innate immune response Complex behaviors in multicellular organisms result from the cooperation of functionally specialized cell types. However, deconvolution of cell mixtures into distinct subpopulations can be challenging due to a lack of, or promiscuous, expression of specific cell surface markers. In my second project, I performed single cell ATACseq over 2000 single cells to discover de novo cell state classifications in resting and pathogen-stimulated DCs. We find significant variation in chromatin accessibility, which can be systematically linked to the activity of specific trans-factors and cis-elements in individual cells. Integrative analysis with single cell RNA-seq, multiparameter flow cytometry, and gene editing knockout studies allowed for the validation of three de novodefined developmental cell states with functionally distinct responses to identical pathogen stimuli. Furthermore, we found intra-cell type variance characterized by activation state heterogeneity even in resting cells. A small subset of resting DCs displayed ‘precocious’ anti-viral enhancers, driven by interferon response factor 3 activity, which resulted in early response to pathogen stimulation. This study highlights principles of cell-type specific networks underlying complex cellular behaviors - and the ability to interrogate these states ‘bottom-up’ using single cell epigenomic profiling. 1. Cheng CS*, Satpathy A*, Buenrostro JD*, Tabaka M*, Wortman I, Gennert D, Greenleaf WJ, Chang HY§, Regev A§. Single-cell chromatin states reveal dynamic transcription factor control priming pathogen response. In preparation. (Contributions: conceived study, designed/performed experiments and designed computational analysis, wrote manuscript) Complete list of Published Work in MyBibliography: https://www.ncbi.nlm.nih.gov/sites/myncbi/christine.cheng.1/bibliography/45392763/public/?sort=date&directi on=ascending D. Research Support Ongoing Research Support Department of Biology, Boston University, New Faculty Startup Fund Role: PI Completed Research Support None. Cheng (PI) 09/01/16-08/31/19 $1,100,000